Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

Year to date, the stock is now down around 12% (as of July 25) as it recently hit a new 52-week low of $410.11. While it has ...

Zoryve’s regulatory and commercial success, together with pipeline progress, supports Arcutis Biotherapeutics’ positive Q2 ...

MannKind Corporation (NASDAQ:MNKD) is one of the penny stocks that will skyrocket. On July 16, H.C. Wainwright assumed ...

New Jersey-based company, Insmed Incorporated (NASDAQ:INSM), is a global biopharmaceutical company developing life‑altering ...

Looking for the latest stock opportunities in August 2025? Click to read these top stock picks to consider adding to your ...

Canada needs more options to get its energy to new markets. This TSX dividend stock is in a prime position to prosper in the coming years.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

The MLP has added a lot more fuel to its growth engine this year. The latest addition is its nearly $2.4 billion acquisition ...

AbbVie Inc. (NYSE: ABBV) stock is up nearly 2% in midday trading after delivering a beat-and-raise in its second-quarter 2025 ...

Silvercrest Asset Management Group Inc. (SAMG) Q2 2025 Management View CEO Richard R. Hough reported "discretionary assets under management increased $1 billion during the second quarter, primarily ...

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% ...